Azithromycin Teva

Medicinal product

(Invented) name

Azithromycin Teva

Active substance (s)

Azitromicinas

Strength

500 mg

Pharmaceutical form

disperguojamosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01FA10, Azithromycin

Marketing authorisation holder

Teva Pharma B.V., Nyderlandai

Date of authorisation

2017-07-10

Date of renewal

2022-06-23

Documents

4093 Azithromycin Teva RPP 2023 06 23.docx

4093 Pakuotės lapelis 2023 06 23.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

PL/H/0423/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Azitromicinas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
68728	83311	1083311	lizdinė plokštelė	N3		Receptinis	LT/1/17/4093/009	Tiekiama	2025-03-31	-	No	-	-	Download
68729	83312	1083312	lizdinė plokštelė	N6		Receptinis	LT/1/17/4093/010	Netiekiama	-	-	No	-	-
68730	83313	1083313	lizdinė plokštelė	N12		Receptinis	LT/1/17/4093/011	Netiekiama	-	-	No	-	-
68731	83314	1083314	lizdinė plokštelė	N24		Receptinis	LT/1/17/4093/012	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-06-23	Perregistruotas
2017-07-10	Registruotas